Review Article
Towards Personalized Medicine Based on Platelet Function Testing for Stent Thrombosis Patients
Table 3
Model of adjusting strategies for antiplatelet therapy while having HPR.
| P2Y12 inhibitor adjusting strategies | From | To |
| Clopidogrel 75 mg 1dd1 | Prasugrel 10 mg 1dd1 or Prasugrel 5 mg 1dd1 (when <60 kg and/or >75 years) | Prasugrel 5 mg 1dd1 | Prasugrel 10 mg 1dd1 | Prasugrel 10 mg 1dd1 | Ticagrelor 90 mg 2dd1 |
|
|